SCHEMBL24124276

SCHEMBL24124276

Cc1cccc(CC(=O)Nc2cccc(C(=O)Nc3ccc([S+]([O-])Nc4ccccc4)cc3)c2)c1N

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 6/20 0.45
KDM4E B2RXH2 2/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
KCNK3 O14649 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
FFAR1 O14842 2/20 0.43
TP53 P04637 2/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
BACE1 P56817 3/20 0.41
GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24124302 0.89 KMT2A (0.49) KMT2ASMN1; SMN2MEN1KDM4EPOLB
SCHEMBL24124286 0.88 KMT2A (0.47) KMT2ASMN1; SMN2MEN1KDM4EPOLB
SCHEMBL24124280 0.83 ANO1 (0.49) KMT2ASMN1; SMN2MEN1KDM4EKCNK3
SCHEMBL30522641 0.82 MAPT (0.58) KMT2ASMN1; SMN2MEN1MAPTALDH1A1
SCHEMBL24124922 0.82 KMT2A (0.47) KMT2ASMN1; SMN2MEN1KDM4EPOLB
SCHEMBL25323225 0.82 MAPT (0.58) KMT2ASMN1; SMN2MEN1MAPTALDH1A1
SCHEMBL24124926 0.79 KCNK3 (0.46) KMT2ASMN1; SMN2MEN1KDM4EPOLB
SCHEMBL24124918 0.77 KMT2A (0.46) KMT2ASMN1; SMN2MEN1KDM4EPOLB
SCHEMBL24124919 0.75 KMT2A (0.59) KMT2ASMN1; SMN2MEN1KDM4EPOLB
SCHEMBL30522642 0.75 KMT2A (0.59) KMT2ASMN1; SMN2MEN1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021257544-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2021-12-23 WO disclosed